��������

Gonorrhea is the second most common sexually transmitted infection (STI) caused by bacteria in the world. In women is mostly asymptomatic and it can cause serious health problems if not treated. Of all the STIs, gonorrhea is the most resistant to antibiotics. Because of widespread resistance, older and cheaper antibiotics have lost their effectiveness in treatment of the infection, and gonorrhea infection may become untreatable.

You can get gonorrhea by having unprotected vaginal, anal, or oral sex with someone who has gonorrhea. You can still get gonorrhea even if you had it in the past and got treatment for it. It can also be transmitted from mother-to-child during childbirth.

Correct and consistent use of condoms significantly decreases the risk of infection during anal, vaginal or oral sexual contact. For all neonates, the  recommends topical ocular prophylaxis for the prevention of gonococcal and chlamydial ophthalmia neonatorum (eye infection).

Many people with gonorrhea do not show any symptoms, with less than half of infected women expressing non-specific symptoms. If you do have symptoms, they can appear in different forms. Women might notice irregular vaginal discharge, pain when urinating, discomfort in the lower part of the stomach, or bleeding from the vagina after sex or between periods. Men might notice pain when urinating, pus-like discharge from the penis, or pain or swelling in one testicle.

In both men and women rectal infection often do not cause symptoms, but in some cases, you may have rectal and anal pain or discharge. Throat infections can also occur and, in most cases, are asymptomatic, but mild sore throat or inflammation in the back of the throat could happen.

Gonorrhea is often asymptomatic in women, and the lack of discernible symptoms results in unrecognized and untreated infections. If left untreated, gonorrhea usually resolves naturally, but can also cause serious health problems. For women this could include pelvic inflammatory disease (PID), which can lead to ectopic pregnancy (pregnancy outside the womb) and inability to have a baby. In men, health problems could include epididymitis (inflammation of the tube that stores and carries sperm at the back of the testicle), urethral stricture (narrowing of the urine canal) and inability to have a baby. The risk of complications increases with repeated infection.

Infants of mothers with gonococcal infection can be infected at delivery, resulting in neonatal conjunctivitis (eye infection) manifesting as purulent ocular discharge and swollen eyelids. Untreated conjunctivitis may lead to scarring and blindness.

Diagnosis is made in a laboratory using different samples, including urine, and vulvovaginal, cervical, and urethral swabs. However, since laboratory diagnostic tests are not available in many countries, a qualified care provider may treat you based on the presence of symptoms such as vaginal and urethral discharge. 

There have been major developments in the diagnosis of gonorrhea including using rapid molecular diagnostic tests, some combined with tests for chlamydia.

The  recommends that local antimicrobial resistance (AMR) data should guide national treatment guidelines.  In settings where local AMR data are not available, WHO suggests dual therapy over single therapy for people with genital or anorectal gonorrhea (conditional recommendation, low quality evidence)

Dual therapy (one of the following):

• ceftriaxone 250 mg intramuscular (IM) as a single dose PLUS azithromycin 1 g orally as a single dose.
• cefixime 400 mg orally as a single dose PLUS azithromycin 1 g orally as a single dose.

With the right treatment, gonorrhea infection can be cured completely. However, it is becoming harder to treat some forms of gonorrhea infection, because the bacteria have developed resistance to nearly all the antibiotics used for its treatment.

However, since laboratory diagnostic tests are not available in many countries, a qualified care provider may treat you based on the presence of symptoms such as vaginal and urethral discharge.

Antimicrobial resistance happens when microorganisms (such as bacteria, fungi, viruses, and parasites) change when they are exposed to antimicrobial drugs (such as antibiotics, antifungals, antivirals, antimalarials, and anthelmintics). Microorganisms that develop antimicrobial resistance are sometimes referred to as "superbugs". As a result, the medicines become ineffective and infections persist in the body, increasing the risk of spread to others. Antimicrobial resistance is an increasingly serious threat to global public health that requires action across all government sectors and society.